Olema Pharmaceuticals Inc (OLMA) — Cash Flow-to-Debt Ratio
Olema Pharmaceuticals Inc (OLMA) has a Cash Flow-to-Debt Ratio of -0.92x as of March 2026, meaning its operating cash flow of $-45.99 Million could theoretically repay -1% of its total liabilities ($50.17 Million) in one year. Explore OLMA cash flow conversion to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Olema Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Olema Pharmaceuticals Inc across 8 annual periods. Also explore Olema Pharmaceuticals Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Olema Pharmaceuticals Inc (2018–2025)
Year-by-year debt coverage analysis for Olema Pharmaceuticals Inc. For market capitalisation and broader financial context, see Olema Pharmaceuticals Inc (OLMA) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.67x | $-146.72 Million | $54.87 Million | ▼ -7.7% |
| 2024 | -2.48x | $-104.35 Million | $42.02 Million | ▲ +31.6% |
| 2023 | -3.63x | $-83.73 Million | $23.05 Million | ▲ +19.9% |
| 2022 | -4.53x | $-82.06 Million | $18.10 Million | ▼ -1.8% |
| 2021 | -4.46x | $-50.69 Million | $11.38 Million | ▼ -2.8% |
| 2020 | -4.33x | $-19.87 Million | $4.58 Million | ▼ -1408.4% |
| 2019 | -0.29x | $-3.08 Million | $10.73 Million | ▼ -26.1% |
| 2018 | -0.23x | $-2.18 Million | $9.55 Million | — |